🇺🇸 FDA

Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9144557

Hematopoietic growth factor mimetic small molecule compounds and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9139520

Selective androgen receptor modulators (SARMs) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9115094

Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions

The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9056102

VEGF-activated trail ligands

The Regents of the University of California · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050378

N2S2 chelate-targeting ligand conjugates

The Board of Regents of the University of Texas System · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9029557

Labeled A4B2 ligands and methods therefor

The Regents of the University of California · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957223

Ligand-conjugated monomers

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946379

Bladder cancer specific ligand peptides

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8920799

Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosi

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865918

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822467

Biaryl oxyacetic acid compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748608

4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selecti

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748633

Selective androgen receptor modulators (SARMs) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685404

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

United States Government as represented by the Department of Veterans Affairs · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680150

Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic g

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648067

Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands

Teva Sante · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642741

Human antibodies to human TNF-like ligand 1A (TL1A)

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614183

Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-depen

Five Prime Therapeutics, Inc. · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580811

Androgen receptor modulator methods

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575123

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic

Tekmira Pharmaceuticals Corporation · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536133

Selective high-affinity polydentate ligands and methods of making such

The Regents of the University of California · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8519158

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8512755

Compact multifunctional ligand to enhance colloidal stability of nanoparticles

United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted